TP53 and ovarian carcinoma: To further investigate the correlation of p53 status with drug sensitivity, we compared the effects of EpoB treatment on the cell cycle of two immortalized ovarian cancer cell lines: a p53−/− null cell line, SKOV3, versus a p53+ wild type cell line, Hey.